304840.KQ
PeopleBio Inc
Price:  
2,560.00 
KRW
Volume:  
799,445.00
Korea, Republic of | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

304840.KQ WACC - Weighted Average Cost of Capital

The WACC of PeopleBio Inc (304840.KQ) is 7.0%.

The Cost of Equity of PeopleBio Inc (304840.KQ) is 6.75%.
The Cost of Debt of PeopleBio Inc (304840.KQ) is 10.95%.

Range Selected
Cost of equity 5.30% - 8.20% 6.75%
Tax rate 22.10% - 22.30% 22.20%
Cost of debt 7.00% - 14.90% 10.95%
WACC 5.4% - 8.7% 7.0%
WACC

304840.KQ WACC calculation

Category Low High
Long-term bond rate 3.1% 3.6%
Equity market risk premium 5.8% 6.8%
Adjusted beta 0.3 0.53
Additional risk adjustments 0.5% 1.0%
Cost of equity 5.30% 8.20%
Tax rate 22.10% 22.30%
Debt/Equity ratio 0.18 0.18
Cost of debt 7.00% 14.90%
After-tax WACC 5.4% 8.7%
Selected WACC 7.0%

304840.KQ's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for 304840.KQ:

cost_of_equity (6.75%) = risk_free_rate (3.35%) + equity_risk_premium (6.30%) * adjusted_beta (0.3) + risk_adjustments (0.75%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.